SKB GER Week ended 07 Aug 2026

Weekly Investor Report

Koenig & Bauer AG · Industrials · Specialty Industrial Machinery

Open interactive chart View report data
Latest close 9.01 EUR
-0.4% latest week
Weekly setup

Mixed setup

The weekly trend is not active. Price is -0.4% below the Trend Line and sits at 14.5% of its 52-week range. The latest completed week returned -0.4%, after a 1.1% four-week move. The latest factor snapshot indicates quality ranks weakly versus its universe; growth is moderate; valuation is inexpensive relative to peers. The latest news-sentiment score is 49/100.

Setup score 32 out of 100
Latest Close 9.01 EUR 7 Aug 2026
1W Return -0.4% latest completed week
4W Return 1.1% short-term follow-through
12W Return -6.7% quarterly tape
Trend Breadth 0.0% 0 of 52 weeks active
Volume Ratio 1.9x vs 13-week average
What is working
  • Activity pressure is positive on the latest completed week.
  • Volume is elevated versus the 13-week average, confirming attention.
What could go wrong
  • The trend backdrop is inactive, so price action has not confirmed a constructive regime.
  • Price is below the Trend Line, which keeps downside pressure in focus.
  • Price is below Fair Value, so the market is still discounting the latest tape.
  • Activity pressure is weak, so confirmation is not yet broad enough.
What to watch next
  • Trend Line remains the key weekly regime level.
  • Activity pressure is the gauge to monitor for confirmation or fade.
  • A volume ratio above 1.5x would show stronger participation in the next move.
Price follow-through -0.4% Latest completed week; four-week move 1.1%. Indicator stack 0/54 Trend and activity pressure are weighted against the latest 12-week confirmation window. Trend backdrop Active The trend backdrop defines the current weekly regime. Patient Capital Recent Activity-pressure buy-signal status for institutional accumulation timing. News sentiment 49/100 14 relevant articles in the latest sentiment read.
01 · Price action

Where price is—and whether the trend supports it

The weekly trend is not active. Price is -0.4% below the Trend Line and sits at 14.5% of its 52-week range. The latest completed week returned -0.4%, after a 1.1% four-week move.

Study the full chart

52-week price path

Price vs Trend Line and Fair Value
Price Trend Line Fair Value
02 · Volume and demand

Is real participation confirming the move?

Latest weekly volume is 1.9x the 13-week average. Participation is unusually strong and confirms that the move is attracting attention.

26-week volume confirmation

Bar height shows volume; colour shows the weekly price direction
13 Feb 20 Feb 27 Feb 6 Mar 13 Mar 20 Mar 27 Mar 3 Apr 10 Apr 17 Apr 24 Apr 1 May 8 May 15 May 22 May 29 May 5 Jun 12 Jun 19 Jun 26 Jun 3 Jul 10 Jul 17 Jul 24 Jul 31 Jul 7 Aug
Up week Down week
Demand beneath price

Activity pressure and institutional-style signals

These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.

Activity pressure path

Latest 0.1312-week average 0.10

12-week confirmation

Trend active0/12Active trend-backdrop weeks in the latest 12-week window.
Positive pressure12/12Weeks with constructive activity pressure in the latest 12-week window.
Positive leadership0/12Weeks with positive relative leadership in the latest 12-week window.
Activity pressure0.13Current proprietary activity-pressure read.
Buy signals3Accumulation signal count in the latest 12 weeks.
Reversal markers0No reversal markers

No recent accumulation markers. No reversal markers.

03 · Momentum and leadership

Is performance persistent—and is the stock leading?

Performance is 1.1% over four weeks, -6.7% over 12 weeks, and -40.2% over one year. The current trend has remained active for 0 consecutive weeks.

Performance by holding period

1W-0.4%
4W1.1%
12W-6.7%
26W-3.7%
52W-40.2%
Active trend streak0 weeks
Active weeks in one year0
Trend breadth0.0%

Activity pressure vs relative leadership

Activity pressureRelative leadership
Pressure0.27Latest activity-pressure read.
Pressure change-12.1%Four-week change in activity pressure.
Leadership-20.70Latest relative-leadership reading.
RS change2.5%Four-week change in relative leadership.
04 · Fundamentals and valuation

What investors are paying for—and the quality behind it

The latest factor snapshot indicates quality ranks weakly versus its universe; growth is moderate; valuation is inexpensive relative to peers.

Open full factor analysis
Factor week 09 Aug 2026 Financial statements through 31 Mar 2026 Field coverage 82% Model confidence 77%

Relative factor standing

Higher display scores are better. Each score is converted from the underlying universe rank, where rank 1 is best.

Overall factor strength41/100Blend of value, momentum, and quality. Underlying universe rank 60; rank 1 is best.
Value82/100Relative valuation strength. Underlying universe rank 19; rank 1 is best.
Quality17/100Profitability and accounting quality. Underlying universe rank 84; rank 1 is best.
Momentum6/100Medium-term price momentum. Underlying universe rank 95; rank 1 is best.
Growth41/100Revenue and earnings growth. Underlying universe rank 60; rank 1 is best.
How to read this

Quality and valuation are separate questions

A strong company can still carry a demanding valuation. This report shows profitability, growth, balance-sheet strength, and the price paid for those characteristics separately.

Value-quality framework46/100Value and quality alignment from the Sharemaestro SVQF framework.

Valuation

How much investors are paying for earnings, sales, and cash flow.

P/E
-
Price divided by trailing earnings.
Price / sales
0.1x
Market value relative to trailing revenue.
EV / EBITDA
12.3x
Enterprise value relative to operating cash earnings.
Free-cash-flow yield
0.9%
Free cash flow as a share of enterprise value.

Business quality

Margins and the return generated on invested capital.

Gross margin
26.3%
Gross profit retained from each unit of revenue.
Operating margin
1.9%
Operating profit retained from revenue.
Free-cash-flow margin
0.2%
Free cash flow generated from revenue.
Return on invested capital
3.9%
Operating return generated on invested capital.

Growth and financial strength

Recent business growth and accounting strength.

Revenue growth
2.2%
Latest one-year revenue growth.
EPS growth
-
Latest one-year earnings-per-share growth.
Free-cash-flow growth
-63.0%
Latest one-year free-cash-flow growth.
Piotroski F-score
7/9
Nine-point accounting-strength checklist.

Shareholder return and balance sheet

Cash returned to owners and financial leverage.

Dividend yield
-
Cash dividends relative to market value.
Buyback yield
0.0%
Net share repurchases relative to market value.
Shareholder yield
0.0%
Dividend yield plus net buyback yield.
Net debt / EBITDA
6.6x
Balance-sheet debt relative to operating cash earnings.
05 · Ownership, options, and sentiment

What other market participants are doing

Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.

Insider activity-

No recent insider transactions are stored for this company.

News sentiment49/100

Weighted news tone is neutral across 14 relevant articles.

1 positive · 12 neutral · 1 negative
Patient CapitalRecent

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

Recent buy signal in the last 8 weeks
06 · Catalysts and risk

What can move the shares—and how volatile the path has been

Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.

Next earnings-No event is currently stored.
Options expected move-Nearest-chain priced movement where available.
52-week drawdown-45.3%Distance below the 52-week high.
13-week volatility3.9%Standard deviation of weekly returns.

Weekly gains and losses

Latest 26 completed weeks

Each bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.

Weeks higher12 of 2614 weeks finished lower.
Best week+9.1%Week of 17 Apr.
Worst week-7.1%Week of 27 Mar.
Latest week-0.4%Week of 7 Aug.

Shape of recent returns

Strong gains4
Modest gains8
Flat weeks0
Modest losses7
Sharp losses7
Recent vol3.9%13-week weekly-return volatility.
Base vol5.0%52-week weekly-return volatility.
Up/down split23/29Count of positive and negative weeks in the 52-week window.
Average skew3.5% / -4.3%Average positive week versus average negative week.
07 · Sector and peer context

Is this stock leading—or simply moving with its group?

Sector and industry breadth distinguish company-specific strength from a broad group move.

08 · Evidence and weekly data

The underlying research record

Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.

Weekly tape28/100

Trend, activity pressure, participation, and risk combine to a 28/100 tape read.

 Indicator analysis32/100

Latest 12-week confirmation: trend 0/12, activity pressure 12/12, relative leadership 0/12.

Activity pressure 0.13; No reversal markers Factors36/100

O'Shaughnessy factor stack blends value, quality, momentum, and confidence.

Buyback Yield rank 70; Small Cap Core rank 33 SVQF46/100

Value and quality alignment from the Sharemaestro SVQF framework.

Composite rank 202.5 of 375 Patient CapitalRecent

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

Recent buy signal in the last 8 weeks Sentiment49/100

Weighted news tone is neutral across 14 relevant articles.

Koenig & Bauer achieves annual targets; starts 2026 strongly Insiders50/100

No recent insider transaction evidence is stored.

 Earnings50/100

No stored earnings event is currently attached to this ticker.
WeekCloseReturnTrend LineFair ValuePressureLeadershipVolumeTrend
7 Aug 20269.01 EUR-0.4%9.05 EUR12.01 EUR0.27-20.7048.2KOff
31 Jul 20269.05 EUR2.8%9.11 EUR12.04 EUR0.22-19.2121.6KOff
24 Jul 20268.80 EUR2.3%9.16 EUR12.09 EUR0.19-20.6611.7KOff
17 Jul 20268.60 EUR-3.5%9.23 EUR12.15 EUR0.23-22.4220.2KOff
10 Jul 20268.91 EUR0.2%9.29 EUR12.21 EUR0.30-21.2314.8KOff
3 Jul 20268.89 EUR5.8%9.35 EUR12.28 EUR0.20-24.402.7KOff
26 Jun 20268.40 EUR-3.1%9.39 EUR12.34 EUR0.21-26.047.4KOff
19 Jun 20268.67 EUR1.8%9.45 EUR12.41 EUR0.32-25.3510.9KOff
12 Jun 20268.52 EUR-6.1%9.48 EUR12.48 EUR0.52-26.225.3KOff
5 Jun 20269.07 EUR3.2%9.53 EUR12.55 EUR0.73-22.506.1KOff
29 May 20268.79 EUR-4.4%9.60 EUR12.61 EUR0.78-26.4633.6KOff
22 May 20269.19 EUR-4.9%9.75 EUR12.67 EUR0.85-23.0487.6KOff
15 May 20269.66 EUR5.9%9.90 EUR12.73 EUR0.79-16.4351.3KOff
8 May 20269.12 EUR-2.1%10.02 EUR12.78 EUR0.84-22.7441.0KOff
How to use this report

This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.

Evidence context